Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 407 followers

Latest posts

Last updated 2 days ago

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca

2 days ago

The forever more popular combination of Padcev and Keytruda has expanded its...

Young people living with PKU take the mic in BioMarin podcast series, TikTok push

2 days ago

The three-part video podcast series features Londyn, 15, and Connor, 20, who...

Apollo inks €3B equity deal for stake in Bayer's contraceptives business

2 days ago

Bayer has addressed its need for a capital infusion under a deal...

FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time

2 days ago

The third time is not the charm for Hengrui Pharma and Elevar...

A $10B deal, China trial scrutiny and highlights from ADA 2026

2 days ago

This week on "The Top Line," we’re covering some of the biggest...

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector

2 days ago

Sanofi has gained FDA approval of its subcutaneous version of Sarclisa, which...

Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials

2 days ago

AstraZeneca signed potential billion-dollar licensing deals with CSPC and Sino Biopharm, Hengrui's...

J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings

2 days ago

After several months of AbbVie leading pharma’s monthly ad spend, Johnson &amp...

Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings

3 days ago

Bleeding disorder patient groups put Sobi, Roche and Novo Nordisk on the...

Clinical Success Is No Longer One Number

3 days ago

In biopharmaceutical R&D, where fewer than 1 in 10 development programs ultimately...

Decision readiness is the next AI advantage

3 days ago

As AI raises the stakes, leaders need more than data. They need...

BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific

3 days ago

BioNTech is on the verge of returning to its oncology roots with...